Resources
Get access to our publications
Publications
2025
2024
2023
2022
2021
2019
2018
2025
February 2025
Validation and Performance of Quantitative BRCA1 and RAD51C Promoter Hypermethylation Testing in Breast and Ovarian Cancers
The Journal of Molecular Diagnostics, Vol. 27, No. 2 February 2025
January 2025
Targeted NGS as a Frontline Strategy to Accelerate the Precision Treatment of Solid and Heme Tumors
2024
2023
2022
August 08, 2022
Quality metrics for enhanced performance of an NGS panel using single-vial amplification technology
November 03, 2022
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for BRCA Methylation Testing?
February 01, 2022
Abnormal TP53 Predicts Risk of Progression in Patients With Barrett’s Esophagus Regardless of a Diagnosis of Dysplasia
2021
2019
Jan 05, 2019
Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients
2018
Aug 28, 2018
Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
Pillar Biosciences Inc., 9 Strathmore Rd., Natick MA, 01760